share_log

Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

Biodexa Pharmaceuticals | 6-K：外国发行人报告（业绩相关）
美股sec公告 ·  05/16 05:01
牛牛AI助手已提取核心信息
Biodexa Pharmaceuticals PLC has announced the distribution of its Annual Report for the fiscal year ending December 31, 2023, along with the Notice of Annual General Meeting (AGM) to its shareholders. The announcement, made on May 15, 2024, includes the provision of proxy forms for both ordinary shareholders and holders of American Depositary Shares to participate in the upcoming AGM. The meeting is scheduled for June 13, 2024, at the company's registered office in Cardiff, United Kingdom. The documents related to the Annual Report and AGM, including proxy forms, have been attached as exhibits to the company's Form 6-K filing with the United States Securities and Exchange Commission for May 2024.
Biodexa Pharmaceuticals PLC has announced the distribution of its Annual Report for the fiscal year ending December 31, 2023, along with the Notice of Annual General Meeting (AGM) to its shareholders. The announcement, made on May 15, 2024, includes the provision of proxy forms for both ordinary shareholders and holders of American Depositary Shares to participate in the upcoming AGM. The meeting is scheduled for June 13, 2024, at the company's registered office in Cardiff, United Kingdom. The documents related to the Annual Report and AGM, including proxy forms, have been attached as exhibits to the company's Form 6-K filing with the United States Securities and Exchange Commission for May 2024.
Biodexa Pharmicals PLC已宣布向其股东分发截至2023年12月31日的财政年度的年度报告以及年度股东大会（AGM）通知。该公告于2024年5月15日发布，包括为普通股东和美国存托股份持有人提供代理表格，以参加即将举行的股东周年大会。会议定于2024年6月13日在该公司位于英国加的夫的注册办事处举行。与年度报告和股东周年大会相关的文件，包括委托书，已作为证物附在公司于2024年5月向美国证券交易委员会提交的6-K表中。
Biodexa Pharmicals PLC已宣布向其股东分发截至2023年12月31日的财政年度的年度报告以及年度股东大会（AGM）通知。该公告于2024年5月15日发布，包括为普通股东和美国存托股份持有人提供代理表格，以参加即将举行的股东周年大会。会议定于2024年6月13日在该公司位于英国加的夫的注册办事处举行。与年度报告和股东周年大会相关的文件，包括委托书，已作为证物附在公司于2024年5月向美国证券交易委员会提交的6-K表中。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

译文内容由第三方软件翻译。


牛牛AI助手部分由第三方人工智能模型基于资讯内容自动生成，只对中国内地以外的地区提供。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。